Neurocrine Biosci
Article Abstract:
The price appreciation potential of the shares of Neurocrine Biosciences Inc. for the years 2010-2012 is discussed. The San Diego, California-based company offers pharmaceutical products for treatment of disorders of the endocrine and nervous systems such as insomnia and mood disorders.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
Neurocrine Biosciences
Article Abstract:
A comparative analysis of the company sales and earnings and the financial details of Neurocrine Biosciences from 1996 - 2003 are illustrated. Projections of the equity price of this company for 2004 - 2005 is made using Value Line estimates.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Myriad Genetics. Neurocrine Biosciences Inc
- Abstracts: Techne Corp. Medarex Inc
- Abstracts: MedImmune Inc. Cyberonics, Inc
- Abstracts: Nektar Therap'tics. Nektar Therapeutics
- Abstracts: Studying the accuracy of managers' perceptions: a research odyssey. Asking a straightforward question: managers' perceptions and managers' emotions